Abstract
Introduction: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive neurodegenerative di­sorder caused by the accumulation of misfolded prion proteins. Molecular classification, based on PRNP codon 129 polymorphisms and the protease-resistant PrPsc fragment, has refined recogni­tion of subtypes and their correlation with specific neuroimaging patterns. Case presentation: We report a 60-year-old patient presenting with progressive instability, late­ral propulsion, generalized polymyoclonus, tremors, paranoid delusions, and vivid hallucinations. Prominent cerebellar signs and gait disturbance were dominant, configuring an ataxic phenotype accompanied by cognitive decline. An extensive workup excluded alternative diagnoses, and the de­tection of 14-3-3 protein in cerebrospinal fluid, along with positive RT-QuIC and diffusion-wei­ghted magnetic resonance imaging (MRI) findings, were compatible with probable sporadic CJD. Remarkably, the MRI revealed an atypical pattern with predominant basal ganglia involvement rather than the common cortical changes, raising MV2K as a radiological hypothesis and underscoring the clinical-radiological heterogeneity of the ataxic presentation. Discussion: CJD has diverse phenotypic variants. Molecular classification and advanced MRI tech­niques, particularly diffusion-weighted imaging (DWI), are crucial for distinguishing between spo­radic subtypes. Identifying atypical presentations, such as ataxic variants with basal ganglia pre­dominance, improves premortem diagnostic certainty in resource-limited settings where molecular subtyping is not widely available. Conclusion: Molecular and neuroimaging-based approaches have substantially deepened the un­derstanding of CJD heterogeneity. This case emphasizes the value of DWI/MRI in identifying atypi­cal ataxic variants and reinforces the importance of integrating biomarker-supported diagnosis and clinical-radiological correlation when approaching this disease.

This publication has 23 references indexed in Scilit: